SECTION F INDUSTRIAL CONSULTANCIES AND COLLABORATIVE RESEARCH

Section F reflects Chain's continuing contact with a wide range of industrial firms. Although not all of the companies listed here had a formal consultancy agreement with him, most of them sought his advice at one time or another and they have been included as part of the general picture of industrial collaboration.

The largest group of papers (F.44 - F.174) relates to Chain's consultancy with the Beecham Group which culminated in 1959 with the isolation of 6-amino-penicillanic acid (the 'nucleus' of the penicillin molecule). Chain continued to be associated with the Beecham Group until his death in 1979 and the surviving papers document the extent of his involvement with the expansion of their research effort after 1959 as well as his friendly personal contacts, particularly with H.G. Lazell (Chairman 1958 - 68).

Attention is also drawn to the very full record of Chain's collaboration with Astra from 1948 to 1957, a period for which documentation in other parts of the collection is rather patchy.

Many of Chain's contacts with industry resulted in the funding of collaborative research projects conducted in his laboratory, both in Rome and, particularly, at Imperial College. Correspondence re the negotiation and administration of such collaborative projects is to be found both here (see the references to this Section under 'Imperial College' in the General Index) and in Section D, especially D.127 - D.130.

Inevitably, with so many contacts in the industrial world, Chain was often responsible for initiating collaborative projects between the various firms with whom he was associated. Such links are noted, but not generally cross-referenced in the catalogue entries which follow. Instead, each firm is included in the General Index with a list of references to this and other sections of the catalogue where appropriate.

AC'CENT INTERNATIONAL INC. F.1-F.3

ADVISORY SERVICES (CLINICAL & GENERAL) LTD. F.4-F.6

AFICO LTD. see NESTLÉ

ALTHEA S.p.A. F.7

AMERICAN CYANAMID COMPANY F.8

ANIC S.p.A. F.9

ANTIBIOTICOS S.A. F.10

ASSORENI F.11

ASTRA F.12-F.41

BAYER F.42, F.43

BEECHAM GROUP LTD. F.44-F.174

BIOCHEMIE GMBH F.175

BRISTOL LABORATORIES INC. F.176-F.178

BRITISH PETROLEUM (BP) F.179

BRITISH PETROLEUM (BP) PROTEINS LTD. F.180, F.181

CALMIC LTD. F.182

CARLO ERBA F.183

CIBA-GEIGY LTD. F.184

COGER S.p.A. F.185

CYANAMID OF GREAT BRITAIN LTD. F.186

EDWARDS HIGH VACUUM F.187

ENI (ENTE NAZIONALE IDROCARBURI) F.188-F.190

FARMITALIA F.191-F.200

FISONS LTD. F.201

GALENIKA F.202

GRÜNENTHAL (CHEMIE GRÜNENTHAL GMBH) F.203-F.211

HINDUSTAN ANTIBIOTICS LTD. F.212-F.215

HOECHST (FARBWERKE HOECHST AG) F.216-F.218

IMPERIAL CHEMICAL INDUSTRIES LTD. (I.C.I.) F.219-F.227

ISF S.p.A. F.228

ISRAEL PENICILLIN AND BIOLOGICAL PRODUCTS CO. F.229

ISTITUTO SIEROTERAPICO E VACCINOGENO TOSCANO "SCLAVO" S.p.A. F.230

LEPETIT S.p.A. F.231-F.233

LILLY RESEARCH LABORATORIES, ELI LILLY AND CO. F.234, F.235

MARKS AND SPENCER LTD. F.236-F.251

MERCK SHARP & DOHME F.252-F.257

MONTECATINI EDISON S.p.A. (later MONTEDISON) F.258-F.267

NATIONAL DRUG COMPANY F.268

NATIONAL IRANIAN OIL COMPANY (N.I.O.C.) F.269-F.281

NESTLÉ ALIMENTANA S.A. F.282-F.292

PFIZER (CHAS. PFIZER & CO. INC.) F.293-F.297

PFLEGER (DR. R. PFLEGER CHEMISCHE FABRIK GMBH) F.298-F.310

PULLMAN ASSOCIATES GMBH F.311

RANK PRECISION INDUSTRIES LTD. F.312, F.313

RANKS HOVIS McDOUGALL LTD. F.314-F.324

REVLON INC. see USV

RICHARDSON-MERRELL INC. F.325

ROCHE PRODUCTS LTD. F.326

LABORATOIRE ROGER BELLON F.327

SANDOZ LTD. F.328-F.330

SCLAVO

LABORATORI BIOCHIMICO-FARMACEUTICI SMIT F.331

SMITH KLEINE & FRENCH LABORATORIES LTD. F.332

WM. UNDERWOOD CO. see AC'CENT INTERNATIONAL

UPJOHN INTERNATIONAL INC. F.333, F.334

USIFROID (SOCIÉTÉ D'UTILISATION SCIENTIFIQUE ET INDUSTRIELLE DU FROID) F.335

USV PHARMACEUTICAL CORPORATION F.336-F.342

WALLACE LABORATORIES F.343, F.344

WESTFALIA SEPARATOR LTD. F.345

<p>see F.230</p>